Dr. Bhuvan Chugh

Dr Bhuvan Chugh is a Medical Oncologist with rich experience in the treatment of solid organ cancers. He has a special interest in breast, thoracic, head & neck and hepato-billiary malignancies. He is the convener for the molecular tumour board at Max Saket and Gurgaon and has a keen interest in precision medicine. He has been an active part of the faculty both in terms of clinical and research work. Have co-authored many chapters, papers & abstracts in various national and international journals and conferences.

Work Experience

• Currently working as Senior Consultant, Medical Oncology at Max Healthcare
• Worked as Associate Consultant, Department of Medical Oncology & Hematology, Medanta, Gurgaon
• Worked as Attending Consultant, Department of Medical Oncology & Hematology, Medanta, Gurgaon

Education & Training

• DNB Medical Oncology-2018, Medanta, the Medicity, Gurgaon, Haryana (NBE)
• DNB General Medicine-2012, (Army Base Hospital, Delhi Cantt, Delhi (NBE)
• MBBS-2007, Rajiv Gandhi University of Health Sciences, Karnataka

Speciality Interest

• Breast Cancer
• Thoracic and Esophageal Cancer
• Gastrointestinal Cancer
• Gynae Cancer
• Genitourinary Cancer

Research Papers & Publications

• Chugh, B. and Vaid, A K. 2020. ‘Key Takeaways from International Guidelines on Gastric Cancer’. Gastric Cancer. Springer Healthcare Education
• Clinico-hematologic and cytogenetic profile in a rare case of pure erythroid leukaemia; Annals of Haematology 98(3); March 2019.
• Myelodysplastic syndromes: Where do we stand? Asian Journal of Oncology. April 2016.
• Outcomes of patients presenting with acute coronary syndrome with vitamin D deficiency. Indian Heart Journal. November 2014.

       PRESENTATIONS

• Abstract Publication in BTG2018, 9th International Hematologic Malignancies Conference held in Seoul, South Korea from March 29-31, 2018.
• A Prospective Study of Clinico-pathological features, Prognostic factors, and Response rates in Advanced Non-small Cell Lung Cancer Patients Eligible for Chemotherapy - A Single Centre Experience at 37th ICON New Delhi. 2017
• A Prospective Observational Study of Clinico-Pathological Features, Prognostic Factors and Treatment Response to Primary Therapy in Multiple Myeloma at a Tertiary Care Centre; Blood 134(Supplement_1):5559-5559; November 2019
• Speaking engagements in various national level conferences